These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Lyketsos CG; Sheppard JM; Steinberg M; Tschanz JA; Norton MC; Steffens DC; Breitner JC Int J Geriatr Psychiatry; 2001 Nov; 16(11):1043-53. PubMed ID: 11746650 [TBL] [Abstract][Full Text] [Related]
3. Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study. Nagata T; Nakajima S; Shinagawa S; Plitman E; Nakayama K; Graff-Guerrero A; Mimura M J Alzheimers Dis; 2017; 60(1):263-272. PubMed ID: 28800334 [TBL] [Abstract][Full Text] [Related]
4. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. Marin DB; Green CR; Schmeidler J; Harvey PD; Lawlor BA; Ryan TM; Aryan M; Davis KL; Mohs RC J Am Geriatr Soc; 1997 Nov; 45(11):1331-8. PubMed ID: 9361658 [TBL] [Abstract][Full Text] [Related]
5. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study. Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study. van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452 [TBL] [Abstract][Full Text] [Related]
7. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637 [TBL] [Abstract][Full Text] [Related]
8. Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence. Kolanowski A; Boltz M; Galik E; Gitlin LN; Kales HC; Resnick B; Van Haitsma KS; Knehans A; Sutterlin JE; Sefcik JS; Liu W; Petrovsky DV; Massimo L; Gilmore-Bykovskyi A; MacAndrew M; Brewster G; Nalls V; Jao YL; Duffort N; Scerpella D Nurs Outlook; 2017; 65(5):515-529. PubMed ID: 28826872 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619 [TBL] [Abstract][Full Text] [Related]
10. Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies. Cummings J; Lai TJ; Hemrungrojn S; Mohandas E; Yun Kim S; Nair G; Dash A CNS Neurosci Ther; 2016 Mar; 22(3):159-66. PubMed ID: 26778658 [TBL] [Abstract][Full Text] [Related]
11. Cerebral dysfunction and psychotic symptoms in Alzheimer's disease. Toone B J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):148-9. PubMed ID: 10896684 [No Abstract] [Full Text] [Related]
12. Prevalence of neuropsychiatric syndromes in Alzheimer's disease (AD). Youn JC; Lee DY; Jhoo JH; Kim KW; Choo IH; Woo JI Arch Gerontol Geriatr; 2011; 52(3):258-63. PubMed ID: 20537736 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease. Gormley N; Rizwan MR Int J Geriatr Psychiatry; 1998 Jun; 13(6):410-4. PubMed ID: 9658277 [TBL] [Abstract][Full Text] [Related]